Optimization of peptide-based cancer vaccine compositions, by sequential screening, using versatile liposomal platform Article Swipe

View

Célia Jacoberger-Foissac , Hanadi Saliba , Cendrine Seguin , Anaïs Brion , Zahra Kakhi , Benoît Frisch , Sylvie Fournel , B. Benoit ·

YOU? · · 2019 · Open Access · · DOI: https://doi.org/10.1016/j.ijpharm.2019.03.002

Related Topics

Concepts

Epitope Adjuvant Peptide vaccine Cancer vaccine Immune system Antigen Cytotoxic T cell Cancer immunotherapy CD8 Immunotherapy Medicine Immunology Biology In vitro Biochemistry

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.1016/j.ijpharm.2019.03.002
OA Status: green
Cited By: 21
References: 55
Related Works: 10
OpenAlex ID: https://openalex.org/W2921794624

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W2921794624

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1016/j.ijpharm.2019.03.002

Digital Object Identifier
Title: Optimization of peptide-based cancer vaccine compositions, by sequential screening, using versatile liposomal platform

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2019

Year of publication
Publication date: 2019-03-15

Full publication date if available
Authors: Célia Jacoberger-Foissac, Hanadi Saliba, Cendrine Seguin, Anaïs Brion, Zahra Kakhi, Benoît Frisch, Sylvie Fournel, B. Benoit

List of authors in order
Landing page: https://doi.org/10.1016/j.ijpharm.2019.03.002

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: green

Open access status per OpenAlex
OA URL: https://hal.science/hal-02185294

Direct OA link when available
Concepts: Epitope, Adjuvant, Peptide vaccine, Cancer vaccine, Immune system, Antigen, Cytotoxic T cell, Cancer immunotherapy, CD8, Immunotherapy, Medicine, Immunology, Biology, In vitro, Biochemistry

Top concepts (fields/topics) attached by OpenAlex
Cited by: 21

Total citation count in OpenAlex
Citations by year (recent): 2025: 2, 2024: 3, 2022: 6, 2021: 6, 2020: 3

Per-year citation counts (last 5 years)
References (count): 55

Number of works referenced by this work
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W2921794624
doi	https://doi.org/10.1016/j.ijpharm.2019.03.002
ids.doi	https://doi.org/10.1016/j.ijpharm.2019.03.002
ids.mag	2921794624
ids.pmid	https://pubmed.ncbi.nlm.nih.gov/30880104
ids.openalex	https://openalex.org/W2921794624
fwci	1.87162144
mesh[0].qualifier_ui	Q000008
mesh[0].descriptor_ui	D000276
mesh[0].is_major_topic	False
mesh[0].qualifier_name	administration & dosage
mesh[0].descriptor_name	Adjuvants, Immunologic
mesh[1].qualifier_ui
mesh[1].descriptor_ui	D000818
mesh[1].is_major_topic	False
mesh[1].qualifier_name
mesh[1].descriptor_name	Animals
mesh[2].qualifier_ui	Q000008
mesh[2].descriptor_ui	D019496
mesh[2].is_major_topic	False
mesh[2].qualifier_name	administration & dosage
mesh[2].descriptor_name	Cancer Vaccines
mesh[3].qualifier_ui	Q000008
mesh[3].descriptor_ui	D000939
mesh[3].is_major_topic	False
mesh[3].qualifier_name	administration & dosage
mesh[3].descriptor_name	Epitopes
mesh[4].qualifier_ui
mesh[4].descriptor_ui	D006388
mesh[4].is_major_topic	False
mesh[4].qualifier_name
mesh[4].descriptor_name	Hemagglutinins
mesh[5].qualifier_ui
mesh[5].descriptor_ui	D052162
mesh[5].is_major_topic	False
mesh[5].qualifier_name
mesh[5].descriptor_name	Human papillomavirus 16
mesh[6].qualifier_ui
mesh[6].descriptor_ui	D008081
mesh[6].is_major_topic	False
mesh[6].qualifier_name
mesh[6].descriptor_name	Liposomes
mesh[7].qualifier_ui	Q000188
mesh[7].descriptor_ui	D008175
mesh[7].is_major_topic	False
mesh[7].qualifier_name	drug therapy
mesh[7].descriptor_name	Lung Neoplasms
mesh[8].qualifier_ui
mesh[8].descriptor_ui	D008297
mesh[8].is_major_topic	False
mesh[8].qualifier_name
mesh[8].descriptor_name	Male
mesh[9].qualifier_ui
mesh[9].descriptor_ui	D008810
mesh[9].is_major_topic	False
mesh[9].qualifier_name
mesh[9].descriptor_name	Mice, Inbred C57BL
mesh[10].qualifier_ui	Q000008
mesh[10].descriptor_ui	D010455
mesh[10].is_major_topic	False
mesh[10].qualifier_name	administration & dosage
mesh[10].descriptor_name	Peptides
mesh[11].qualifier_ui
mesh[11].descriptor_ui	D014764
mesh[11].is_major_topic	False
mesh[11].qualifier_name
mesh[11].descriptor_name	Viral Proteins
mesh[12].qualifier_ui	Q000008
mesh[12].descriptor_ui	D000276
mesh[12].is_major_topic	False
mesh[12].qualifier_name	administration & dosage
mesh[12].descriptor_name	Adjuvants, Immunologic
mesh[13].qualifier_ui
mesh[13].descriptor_ui	D000818
mesh[13].is_major_topic	False
mesh[13].qualifier_name
mesh[13].descriptor_name	Animals
mesh[14].qualifier_ui	Q000008
mesh[14].descriptor_ui	D019496
mesh[14].is_major_topic	False
mesh[14].qualifier_name	administration & dosage
mesh[14].descriptor_name	Cancer Vaccines
mesh[15].qualifier_ui	Q000008
mesh[15].descriptor_ui	D000939
mesh[15].is_major_topic	False
mesh[15].qualifier_name	administration & dosage
mesh[15].descriptor_name	Epitopes
mesh[16].qualifier_ui
mesh[16].descriptor_ui	D006388
mesh[16].is_major_topic	False
mesh[16].qualifier_name
mesh[16].descriptor_name	Hemagglutinins
mesh[17].qualifier_ui
mesh[17].descriptor_ui	D052162
mesh[17].is_major_topic	False
mesh[17].qualifier_name
mesh[17].descriptor_name	Human papillomavirus 16
mesh[18].qualifier_ui
mesh[18].descriptor_ui	D008081
mesh[18].is_major_topic	False
mesh[18].qualifier_name
mesh[18].descriptor_name	Liposomes
mesh[19].qualifier_ui	Q000188
mesh[19].descriptor_ui	D008175
mesh[19].is_major_topic	False
mesh[19].qualifier_name	drug therapy
mesh[19].descriptor_name	Lung Neoplasms
mesh[20].qualifier_ui
mesh[20].descriptor_ui	D008297
mesh[20].is_major_topic	False
mesh[20].qualifier_name
mesh[20].descriptor_name	Male
mesh[21].qualifier_ui
mesh[21].descriptor_ui	D008810
mesh[21].is_major_topic	False
mesh[21].qualifier_name
mesh[21].descriptor_name	Mice, Inbred C57BL
mesh[22].qualifier_ui	Q000008
mesh[22].descriptor_ui	D010455
mesh[22].is_major_topic	False
mesh[22].qualifier_name	administration & dosage
mesh[22].descriptor_name	Peptides
mesh[23].qualifier_ui
mesh[23].descriptor_ui	D014764
mesh[23].is_major_topic	False
mesh[23].qualifier_name
mesh[23].descriptor_name	Viral Proteins
type	article
title	Optimization of peptide-based cancer vaccine compositions, by sequential screening, using versatile liposomal platform
biblio.issue
biblio.volume	562
biblio.last_page	350
biblio.first_page	342
grants[0].funder	https://openalex.org/F4320322147
grants[0].award_id
grants[0].funder_display_name	Université de Strasbourg
grants[1].funder	https://openalex.org/F4320322363
grants[1].award_id	IP-SCG-JD-14779
grants[1].funder_display_name	Ligue Contre le Cancer
topics[0].id	https://openalex.org/T10580
topics[0].field.id	https://openalex.org/fields/24
topics[0].field.display_name	Immunology and Microbiology
topics[0].score	1.0
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/2403
topics[0].subfield.display_name	Immunology
topics[0].display_name	Immunotherapy and Immune Responses
topics[1].id	https://openalex.org/T10725
topics[1].field.id	https://openalex.org/fields/13
topics[1].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[1].score	0.9993000030517578
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/1312
topics[1].subfield.display_name	Molecular Biology
topics[1].display_name	RNA Interference and Gene Delivery
topics[2].id	https://openalex.org/T11103
topics[2].field.id	https://openalex.org/fields/24
topics[2].field.display_name	Immunology and Microbiology
topics[2].score	0.9988999962806702
topics[2].domain.id	https://openalex.org/domains/1
topics[2].domain.display_name	Life Sciences
topics[2].subfield.id	https://openalex.org/subfields/2404
topics[2].subfield.display_name	Microbiology
topics[2].display_name	Antimicrobial Peptides and Activities
funders[0].id	https://openalex.org/F4320322147
funders[0].ror	https://ror.org/00pg6eq24
funders[0].display_name	Université de Strasbourg
funders[1].id	https://openalex.org/F4320322363
funders[1].ror	https://ror.org/00rkrv905
funders[1].display_name	Ligue Contre le Cancer
is_xpac	False
apc_list.value	4190
apc_list.currency	USD
apc_list.value_usd	4190
apc_paid
concepts[0].id	https://openalex.org/C195616568
concepts[0].level	3
concepts[0].score	0.8562178611755371
concepts[0].wikidata	https://www.wikidata.org/wiki/Q128711
concepts[0].display_name	Epitope
concepts[1].id	https://openalex.org/C2777863537
concepts[1].level	2
concepts[1].score	0.8184617757797241
concepts[1].wikidata	https://www.wikidata.org/wiki/Q357896
concepts[1].display_name	Adjuvant
concepts[2].id	https://openalex.org/C2776789287
concepts[2].level	4
concepts[2].score	0.6070841550827026
concepts[2].wikidata	https://www.wikidata.org/wiki/Q7166532
concepts[2].display_name	Peptide vaccine
concepts[3].id	https://openalex.org/C2778378633
concepts[3].level	4
concepts[3].score	0.6032534241676331
concepts[3].wikidata	https://www.wikidata.org/wiki/Q2378309
concepts[3].display_name	Cancer vaccine
concepts[4].id	https://openalex.org/C8891405
concepts[4].level	2
concepts[4].score	0.5319939851760864
concepts[4].wikidata	https://www.wikidata.org/wiki/Q1059
concepts[4].display_name	Immune system
concepts[5].id	https://openalex.org/C147483822
concepts[5].level	2
concepts[5].score	0.5159074068069458
concepts[5].wikidata	https://www.wikidata.org/wiki/Q103537
concepts[5].display_name	Antigen
concepts[6].id	https://openalex.org/C154317977
concepts[6].level	3
concepts[6].score	0.4767361879348755
concepts[6].wikidata	https://www.wikidata.org/wiki/Q376266
concepts[6].display_name	Cytotoxic T cell
concepts[7].id	https://openalex.org/C2780674031
concepts[7].level	4
concepts[7].score	0.47175177931785583
concepts[7].wikidata	https://www.wikidata.org/wiki/Q2012719
concepts[7].display_name	Cancer immunotherapy
concepts[8].id	https://openalex.org/C167672396
concepts[8].level	3
concepts[8].score	0.4221935570240021
concepts[8].wikidata	https://www.wikidata.org/wiki/Q417800
concepts[8].display_name	CD8
concepts[9].id	https://openalex.org/C2777701055
concepts[9].level	3
concepts[9].score	0.38985568284988403
concepts[9].wikidata	https://www.wikidata.org/wiki/Q1427096
concepts[9].display_name	Immunotherapy
concepts[10].id	https://openalex.org/C71924100
concepts[10].level	0
concepts[10].score	0.34487706422805786
concepts[10].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[10].display_name	Medicine
concepts[11].id	https://openalex.org/C203014093
concepts[11].level	1
concepts[11].score	0.3171616494655609
concepts[11].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[11].display_name	Immunology
concepts[12].id	https://openalex.org/C86803240
concepts[12].level	0
concepts[12].score	0.31629833579063416
concepts[12].wikidata	https://www.wikidata.org/wiki/Q420
concepts[12].display_name	Biology
concepts[13].id	https://openalex.org/C202751555
concepts[13].level	2
concepts[13].score	0.08594632148742676
concepts[13].wikidata	https://www.wikidata.org/wiki/Q221681
concepts[13].display_name	In vitro
concepts[14].id	https://openalex.org/C55493867
concepts[14].level	1
concepts[14].score	0.08237051963806152
concepts[14].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[14].display_name	Biochemistry
keywords[0].id	https://openalex.org/keywords/epitope
keywords[0].score	0.8562178611755371
keywords[0].display_name	Epitope
keywords[1].id	https://openalex.org/keywords/adjuvant
keywords[1].score	0.8184617757797241
keywords[1].display_name	Adjuvant
keywords[2].id	https://openalex.org/keywords/peptide-vaccine
keywords[2].score	0.6070841550827026
keywords[2].display_name	Peptide vaccine
keywords[3].id	https://openalex.org/keywords/cancer-vaccine
keywords[3].score	0.6032534241676331
keywords[3].display_name	Cancer vaccine
keywords[4].id	https://openalex.org/keywords/immune-system
keywords[4].score	0.5319939851760864
keywords[4].display_name	Immune system
keywords[5].id	https://openalex.org/keywords/antigen
keywords[5].score	0.5159074068069458
keywords[5].display_name	Antigen
keywords[6].id	https://openalex.org/keywords/cytotoxic-t-cell
keywords[6].score	0.4767361879348755
keywords[6].display_name	Cytotoxic T cell
keywords[7].id	https://openalex.org/keywords/cancer-immunotherapy
keywords[7].score	0.47175177931785583
keywords[7].display_name	Cancer immunotherapy
keywords[8].id	https://openalex.org/keywords/cd8
keywords[8].score	0.4221935570240021
keywords[8].display_name	CD8
keywords[9].id	https://openalex.org/keywords/immunotherapy
keywords[9].score	0.38985568284988403
keywords[9].display_name	Immunotherapy
keywords[10].id	https://openalex.org/keywords/medicine
keywords[10].score	0.34487706422805786
keywords[10].display_name	Medicine
keywords[11].id	https://openalex.org/keywords/immunology
keywords[11].score	0.3171616494655609
keywords[11].display_name	Immunology
keywords[12].id	https://openalex.org/keywords/biology
keywords[12].score	0.31629833579063416
keywords[12].display_name	Biology
keywords[13].id	https://openalex.org/keywords/in-vitro
keywords[13].score	0.08594632148742676
keywords[13].display_name	In vitro
keywords[14].id	https://openalex.org/keywords/biochemistry
keywords[14].score	0.08237051963806152
keywords[14].display_name	Biochemistry
language	en
locations[0].id	doi:10.1016/j.ijpharm.2019.03.002
locations[0].is_oa	False
locations[0].source.id	https://openalex.org/S131016564
locations[0].source.issn	0378-5173, 1873-3476
locations[0].source.type	journal
locations[0].source.is_oa	False
locations[0].source.issn_l	0378-5173
locations[0].source.is_core	True
locations[0].source.is_in_doaj	False
locations[0].source.display_name	International Journal of Pharmaceutics
locations[0].source.host_organization	https://openalex.org/P4310320990
locations[0].source.host_organization_name	Elsevier BV
locations[0].source.host_organization_lineage	https://openalex.org/P4310320990
locations[0].license
locations[0].pdf_url
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	International Journal of Pharmaceutics
locations[0].landing_page_url	https://doi.org/10.1016/j.ijpharm.2019.03.002
locations[1].id	pmid:30880104
locations[1].is_oa	False
locations[1].source.id	https://openalex.org/S4306525036
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	PubMed
locations[1].source.host_organization	https://openalex.org/I1299303238
locations[1].source.host_organization_name	National Institutes of Health
locations[1].source.host_organization_lineage	https://openalex.org/I1299303238
locations[1].license
locations[1].pdf_url
locations[1].version	publishedVersion
locations[1].raw_type
locations[1].license_id
locations[1].is_accepted	True
locations[1].is_published	True
locations[1].raw_source_name	International journal of pharmaceutics
locations[1].landing_page_url	https://pubmed.ncbi.nlm.nih.gov/30880104
locations[2].id	pmh:oai:HAL:hal-02185294v1
locations[2].is_oa	True
locations[2].source.id	https://openalex.org/S4306402512
locations[2].source.issn
locations[2].source.type	repository
locations[2].source.is_oa	False
locations[2].source.issn_l
locations[2].source.is_core	False
locations[2].source.is_in_doaj	False
locations[2].source.display_name	HAL (Le Centre pour la Communication Scientifique Directe)
locations[2].source.host_organization	https://openalex.org/I1294671590
locations[2].source.host_organization_name	Centre National de la Recherche Scientifique
locations[2].source.host_organization_lineage	https://openalex.org/I1294671590
locations[2].license	other-oa
locations[2].pdf_url
locations[2].version	submittedVersion
locations[2].raw_type	Journal articles
locations[2].license_id	https://openalex.org/licenses/other-oa
locations[2].is_accepted	False
locations[2].is_published	False
locations[2].raw_source_name	International Journal of Pharmaceutics, 2019, 562, pp.342-350. ⟨10.1016/j.ijpharm.2019.03.002⟩
locations[2].landing_page_url	https://hal.science/hal-02185294
indexed_in	crossref, pubmed
authorships[0].author.id	https://openalex.org/A5082553999
authorships[0].author.orcid	https://orcid.org/0000-0002-2756-6923
authorships[0].author.display_name	Célia Jacoberger-Foissac
authorships[0].countries	FR
authorships[0].affiliations[0].institution_ids	https://openalex.org/I4210093067
authorships[0].affiliations[0].raw_affiliation_string	CAMB - Conception et application de molécules bioactives (Faculté de Pharmacie 74 route du Rhin BP 60024 67401 Illkirch Cedex - France)
authorships[0].institutions[0].id	https://openalex.org/I4210093067
authorships[0].institutions[0].ror	https://ror.org/00rh71z37
authorships[0].institutions[0].type	facility
authorships[0].institutions[0].lineage	https://openalex.org/I1294671590, https://openalex.org/I1294671590, https://openalex.org/I4210093067, https://openalex.org/I4210128300, https://openalex.org/I68947357
authorships[0].institutions[0].country_code	FR
authorships[0].institutions[0].display_name	Laboratoire de Chémo-biologie synthétique et thérapeutique
authorships[0].author_position	first
authorships[0].raw_author_name	Célia Jacoberger-Foissac
authorships[0].is_corresponding	False
authorships[0].raw_affiliation_strings	CAMB - Conception et application de molécules bioactives (Faculté de Pharmacie 74 route du Rhin BP 60024 67401 Illkirch Cedex - France)
authorships[1].author.id	https://openalex.org/A5028104570
authorships[1].author.orcid	https://orcid.org/0000-0002-4658-5652
authorships[1].author.display_name	Hanadi Saliba
authorships[1].countries	FR
authorships[1].affiliations[0].institution_ids	https://openalex.org/I4210093067
authorships[1].affiliations[0].raw_affiliation_string	CAMB - Conception et application de molécules bioactives (Faculté de Pharmacie 74 route du Rhin BP 60024 67401 Illkirch Cedex - France)
authorships[1].institutions[0].id	https://openalex.org/I4210093067
authorships[1].institutions[0].ror	https://ror.org/00rh71z37
authorships[1].institutions[0].type	facility
authorships[1].institutions[0].lineage	https://openalex.org/I1294671590, https://openalex.org/I1294671590, https://openalex.org/I4210093067, https://openalex.org/I4210128300, https://openalex.org/I68947357
authorships[1].institutions[0].country_code	FR
authorships[1].institutions[0].display_name	Laboratoire de Chémo-biologie synthétique et thérapeutique
authorships[1].author_position	middle
authorships[1].raw_author_name	Hanadi Saliba
authorships[1].is_corresponding	False
authorships[1].raw_affiliation_strings	CAMB - Conception et application de molécules bioactives (Faculté de Pharmacie 74 route du Rhin BP 60024 67401 Illkirch Cedex - France)
authorships[2].author.id	https://openalex.org/A5077274160
authorships[2].author.orcid	https://orcid.org/0000-0002-1091-1081
authorships[2].author.display_name	Cendrine Seguin
authorships[2].countries	FR
authorships[2].affiliations[0].institution_ids	https://openalex.org/I4210093067
authorships[2].affiliations[0].raw_affiliation_string	CAMB - Conception et application de molécules bioactives (Faculté de Pharmacie 74 route du Rhin BP 60024 67401 Illkirch Cedex - France)
authorships[2].institutions[0].id	https://openalex.org/I4210093067
authorships[2].institutions[0].ror	https://ror.org/00rh71z37
authorships[2].institutions[0].type	facility
authorships[2].institutions[0].lineage	https://openalex.org/I1294671590, https://openalex.org/I1294671590, https://openalex.org/I4210093067, https://openalex.org/I4210128300, https://openalex.org/I68947357
authorships[2].institutions[0].country_code	FR
authorships[2].institutions[0].display_name	Laboratoire de Chémo-biologie synthétique et thérapeutique
authorships[2].author_position	middle
authorships[2].raw_author_name	Cendrine Seguin
authorships[2].is_corresponding	False
authorships[2].raw_affiliation_strings	CAMB - Conception et application de molécules bioactives (Faculté de Pharmacie 74 route du Rhin BP 60024 67401 Illkirch Cedex - France)
authorships[3].author.id	https://openalex.org/A5062237949
authorships[3].author.orcid
authorships[3].author.display_name	Anaïs Brion
authorships[3].countries	FR
authorships[3].affiliations[0].institution_ids	https://openalex.org/I4210093067
authorships[3].affiliations[0].raw_affiliation_string	CAMB - Conception et application de molécules bioactives (Faculté de Pharmacie 74 route du Rhin BP 60024 67401 Illkirch Cedex - France)
authorships[3].institutions[0].id	https://openalex.org/I4210093067
authorships[3].institutions[0].ror	https://ror.org/00rh71z37
authorships[3].institutions[0].type	facility
authorships[3].institutions[0].lineage	https://openalex.org/I1294671590, https://openalex.org/I1294671590, https://openalex.org/I4210093067, https://openalex.org/I4210128300, https://openalex.org/I68947357
authorships[3].institutions[0].country_code	FR
authorships[3].institutions[0].display_name	Laboratoire de Chémo-biologie synthétique et thérapeutique
authorships[3].author_position	middle
authorships[3].raw_author_name	Anaïs Brion
authorships[3].is_corresponding	False
authorships[3].raw_affiliation_strings	CAMB - Conception et application de molécules bioactives (Faculté de Pharmacie 74 route du Rhin BP 60024 67401 Illkirch Cedex - France)
authorships[4].author.id	https://openalex.org/A5017025018
authorships[4].author.orcid
authorships[4].author.display_name	Zahra Kakhi
authorships[4].countries	FR
authorships[4].affiliations[0].institution_ids	https://openalex.org/I4210093067
authorships[4].affiliations[0].raw_affiliation_string	CAMB - Conception et application de molécules bioactives (Faculté de Pharmacie 74 route du Rhin BP 60024 67401 Illkirch Cedex - France)
authorships[4].institutions[0].id	https://openalex.org/I4210093067
authorships[4].institutions[0].ror	https://ror.org/00rh71z37
authorships[4].institutions[0].type	facility
authorships[4].institutions[0].lineage	https://openalex.org/I1294671590, https://openalex.org/I1294671590, https://openalex.org/I4210093067, https://openalex.org/I4210128300, https://openalex.org/I68947357
authorships[4].institutions[0].country_code	FR
authorships[4].institutions[0].display_name	Laboratoire de Chémo-biologie synthétique et thérapeutique
authorships[4].author_position	middle
authorships[4].raw_author_name	Zahra Kakhi
authorships[4].is_corresponding	False
authorships[4].raw_affiliation_strings	CAMB - Conception et application de molécules bioactives (Faculté de Pharmacie 74 route du Rhin BP 60024 67401 Illkirch Cedex - France)
authorships[5].author.id	https://openalex.org/A5075614630
authorships[5].author.orcid
authorships[5].author.display_name	Benoît Frisch
authorships[5].countries	FR
authorships[5].affiliations[0].institution_ids	https://openalex.org/I4210093067
authorships[5].affiliations[0].raw_affiliation_string	CAMB - Conception et application de molécules bioactives (Faculté de Pharmacie 74 route du Rhin BP 60024 67401 Illkirch Cedex - France)
authorships[5].institutions[0].id	https://openalex.org/I4210093067
authorships[5].institutions[0].ror	https://ror.org/00rh71z37
authorships[5].institutions[0].type	facility
authorships[5].institutions[0].lineage	https://openalex.org/I1294671590, https://openalex.org/I1294671590, https://openalex.org/I4210093067, https://openalex.org/I4210128300, https://openalex.org/I68947357
authorships[5].institutions[0].country_code	FR
authorships[5].institutions[0].display_name	Laboratoire de Chémo-biologie synthétique et thérapeutique
authorships[5].author_position	middle
authorships[5].raw_author_name	Benoît Frisch
authorships[5].is_corresponding	False
authorships[5].raw_affiliation_strings	CAMB - Conception et application de molécules bioactives (Faculté de Pharmacie 74 route du Rhin BP 60024 67401 Illkirch Cedex - France)
authorships[6].author.id	https://openalex.org/A5001030779
authorships[6].author.orcid	https://orcid.org/0000-0003-3583-6548
authorships[6].author.display_name	Sylvie Fournel
authorships[6].countries	FR
authorships[6].affiliations[0].institution_ids	https://openalex.org/I4210093067
authorships[6].affiliations[0].raw_affiliation_string	CAMB - Conception et application de molécules bioactives (Faculté de Pharmacie 74 route du Rhin BP 60024 67401 Illkirch Cedex - France)
authorships[6].institutions[0].id	https://openalex.org/I4210093067
authorships[6].institutions[0].ror	https://ror.org/00rh71z37
authorships[6].institutions[0].type	facility
authorships[6].institutions[0].lineage	https://openalex.org/I1294671590, https://openalex.org/I1294671590, https://openalex.org/I4210093067, https://openalex.org/I4210128300, https://openalex.org/I68947357
authorships[6].institutions[0].country_code	FR
authorships[6].institutions[0].display_name	Laboratoire de Chémo-biologie synthétique et thérapeutique
authorships[6].author_position	middle
authorships[6].raw_author_name	Sylvie Fournel
authorships[6].is_corresponding	False
authorships[6].raw_affiliation_strings	CAMB - Conception et application de molécules bioactives (Faculté de Pharmacie 74 route du Rhin BP 60024 67401 Illkirch Cedex - France)
authorships[7].author.id	https://openalex.org/A5009119950
authorships[7].author.orcid	https://orcid.org/0000-0002-8422-9413
authorships[7].author.display_name	B. Benoit
authorships[7].countries	FR
authorships[7].affiliations[0].institution_ids	https://openalex.org/I68947357
authorships[7].affiliations[0].raw_affiliation_string	UNISTRA - Université de Strasbourg (4 rue Blaise Pascal - CS 90032 - 67081 Strasbourg cedex - France)
authorships[7].institutions[0].id	https://openalex.org/I68947357
authorships[7].institutions[0].ror	https://ror.org/00pg6eq24
authorships[7].institutions[0].type	education
authorships[7].institutions[0].lineage	https://openalex.org/I68947357
authorships[7].institutions[0].country_code	FR
authorships[7].institutions[0].display_name	Université de Strasbourg
authorships[7].author_position	last
authorships[7].raw_author_name	Béatrice Heurtault
authorships[7].is_corresponding	False
authorships[7].raw_affiliation_strings	UNISTRA - Université de Strasbourg (4 rue Blaise Pascal - CS 90032 - 67081 Strasbourg cedex - France)
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://hal.science/hal-02185294
open_access.oa_status	green
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Optimization of peptide-based cancer vaccine compositions, by sequential screening, using versatile liposomal platform
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10580
primary_topic.field.id	https://openalex.org/fields/24
primary_topic.field.display_name	Immunology and Microbiology
primary_topic.score	1.0
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2403
primary_topic.subfield.display_name	Immunology
primary_topic.display_name	Immunotherapy and Immune Responses
related_works	https://openalex.org/W4205364493, https://openalex.org/W2363997565, https://openalex.org/W4321482651, https://openalex.org/W2002432836, https://openalex.org/W2389962403, https://openalex.org/W2576706197, https://openalex.org/W4224084752, https://openalex.org/W1988102572, https://openalex.org/W4386605754, https://openalex.org/W2093473090
cited_by_count	21
counts_by_year[0].year	2025
counts_by_year[0].cited_by_count	2
counts_by_year[1].year	2024
counts_by_year[1].cited_by_count	3
counts_by_year[2].year	2022
counts_by_year[2].cited_by_count	6
counts_by_year[3].year	2021
counts_by_year[3].cited_by_count	6
counts_by_year[4].year	2020
counts_by_year[4].cited_by_count	3
counts_by_year[5].year	2019
counts_by_year[5].cited_by_count	1
locations_count	3
best_oa_location.id	pmh:oai:HAL:hal-02185294v1
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S4306402512
best_oa_location.source.issn
best_oa_location.source.type	repository
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l
best_oa_location.source.is_core	False
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	HAL (Le Centre pour la Communication Scientifique Directe)
best_oa_location.source.host_organization	https://openalex.org/I1294671590
best_oa_location.source.host_organization_name	Centre National de la Recherche Scientifique
best_oa_location.source.host_organization_lineage	https://openalex.org/I1294671590
best_oa_location.license	other-oa
best_oa_location.pdf_url
best_oa_location.version	submittedVersion
best_oa_location.raw_type	Journal articles
best_oa_location.license_id	https://openalex.org/licenses/other-oa
best_oa_location.is_accepted	False
best_oa_location.is_published	False
best_oa_location.raw_source_name	International Journal of Pharmaceutics, 2019, 562, pp.342-350. ⟨10.1016/j.ijpharm.2019.03.002⟩
best_oa_location.landing_page_url	https://hal.science/hal-02185294
primary_location.id	doi:10.1016/j.ijpharm.2019.03.002
primary_location.is_oa	False
primary_location.source.id	https://openalex.org/S131016564
primary_location.source.issn	0378-5173, 1873-3476
primary_location.source.type	journal
primary_location.source.is_oa	False
primary_location.source.issn_l	0378-5173
primary_location.source.is_core	True
primary_location.source.is_in_doaj	False
primary_location.source.display_name	International Journal of Pharmaceutics
primary_location.source.host_organization	https://openalex.org/P4310320990
primary_location.source.host_organization_name	Elsevier BV
primary_location.source.host_organization_lineage	https://openalex.org/P4310320990
primary_location.license
primary_location.pdf_url
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	International Journal of Pharmaceutics
primary_location.landing_page_url	https://doi.org/10.1016/j.ijpharm.2019.03.002
publication_date	2019-03-15
publication_year	2019
referenced_works	https://openalex.org/W1982554619, https://openalex.org/W1982752226, https://openalex.org/W1970160028, https://openalex.org/W2125751260, https://openalex.org/W2603780899, https://openalex.org/W2765869937, https://openalex.org/W2062398277, https://openalex.org/W2078364862, https://openalex.org/W2394725514, https://openalex.org/W2088599017, https://openalex.org/W2020414454, https://openalex.org/W1562306078, https://openalex.org/W2611130520, https://openalex.org/W1992488505, https://openalex.org/W2022135107, https://openalex.org/W2030554898, https://openalex.org/W2073423503, https://openalex.org/W2051912261, https://openalex.org/W2179111917, https://openalex.org/W2467123341, https://openalex.org/W2000590130, https://openalex.org/W2046041427, https://openalex.org/W6679544476, https://openalex.org/W2415527696, https://openalex.org/W2135915203, https://openalex.org/W2086162122, https://openalex.org/W1995806513, https://openalex.org/W2023715115, https://openalex.org/W6640740567, https://openalex.org/W2083613729, https://openalex.org/W1938515409, https://openalex.org/W2072133358, https://openalex.org/W2142294608, https://openalex.org/W2770739873, https://openalex.org/W2063366670, https://openalex.org/W2041153276, https://openalex.org/W2294927533, https://openalex.org/W2088658776, https://openalex.org/W2037653136, https://openalex.org/W2133707169, https://openalex.org/W2000582752, https://openalex.org/W2070722434, https://openalex.org/W2791512052, https://openalex.org/W2321587054, https://openalex.org/W2110443462, https://openalex.org/W2065115599, https://openalex.org/W2061510929, https://openalex.org/W2059453959, https://openalex.org/W6638764703, https://openalex.org/W2006987944, https://openalex.org/W2275344300, https://openalex.org/W1966916002, https://openalex.org/W1832506037, https://openalex.org/W1949342640, https://openalex.org/W2133255811
referenced_works_count	55
abstract_inverted_index
cited_by_percentile_year.max	98
cited_by_percentile_year.min	90
countries_distinct_count	1
institutions_distinct_count	8
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.7400000095367432
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.81518095
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False